diabetic kidney disease

Showing 26 - 50 of 98

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes, Cardiovascular Complication, Diabetic Kidney Disease Trial (Intensive guideline algorithm implementation,

Not yet recruiting
  • Type 2 Diabetes
  • +2 more
  • Intensive guideline algorithm implementation
  • Conventional guideline algorithm implementation
  • (no location specified)
Aug 6, 2022

Diabetic Kidney Disease Trial in United States (TMX-049, Placebo)

Completed
  • Diabetic Kidney Disease
  • Flagstaff, Arizona
  • +54 more
Jul 28, 2022

Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases Trial in Aurora (Metformin Hcl 1000Mg Tab, Aminohippurate

Recruiting
  • Type 1 Diabetes
  • +4 more
  • Metformin Hcl 1000Mg Tab
  • +3 more
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Jul 28, 2022

AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes

Recruiting
  • Type1 Diabetes Mellitus
  • +7 more
  • Blood draw
  • +2 more
  • Aurora, Colorado
    Children's Hospital Colorado
Jul 28, 2022

Control of Renal Oxygen Consumption, Mitochondrial Dysfunction,

Active, not recruiting
  • Diabetic Kidney Disease
  • +10 more
  • Aminohippurate Sodium Inj 20%
  • +3 more
  • Aurora, Colorado
    Children's Hospital Colorado
Jul 19, 2022

Diabetic Kidney Disease, Cognitive Function, Weight Loss Trial in San Antonio (mHealth + low-fat diet, mHealth +

Active, not recruiting
  • Diabetic Kidney Disease
  • +4 more
  • mHealth + low-fat diet
  • mHealth + low-carb/ketogenic diet
  • San Antonio, Texas
  • +1 more
Jul 1, 2022

Diabetic Kidney Disease Trial in Sendai (Bardoxolone methyl, Placebo)

Active, not recruiting
  • Diabetic Kidney Disease
  • Bardoxolone methyl
  • Placebo
  • Sendai, Miyagi, Japan
    Japan Community Health care Organization Sendai Hospital
Jun 26, 2022

Early Screening and Diagnosis in Diabetic Nephropathy

Enrolling by invitation
  • Diabetic Kidney Disease
    • Beijing, China
    • +49 more
    May 23, 2022

    Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

    Recruiting
    • Diabetic Kidney Disease
    • Liverpool, New South Wales, Australia
    • +6 more
    May 17, 2022

    Decision Impact Trial of KidneyIntelX

    Recruiting
    • Diabetic Kidney Disease
    • KidneyIntelX
    • Slingerlands, New York
      Delmar Family Medicine
    Apr 25, 2022

    Real World Evidence Clinical Utility Study of KidneyIntelX

    Recruiting
    • Chronic Kidney Diseases
    • Diabetic Kidney Disease
    • KidneyIntelX
    • New York, New York
      Mount Sinai Health System
    Apr 25, 2022

    Diabetic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

    Completed
    • Diabetic Kidney Disease
    • Finerenone (BAY94-8862)
    • Placebo
    • Birmingham, Alabama
    • +974 more
    Apr 13, 2022

    Diabetic Kidney Disease Trial in Jakarta Pusat (Calcitriol capsules, Placebo)

    Not yet recruiting
    • Diabetic Kidney Disease
    • Calcitriol capsules
    • Placebo
    • Jakarta Pusat, DKI Jakarta, Indonesia
      Dr. Cipto Mangunkusumo Hospital
    Mar 25, 2022

    Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy

    Recruiting
    • Diabetic Kidney Disease
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Mar 16, 2022

      Diabetic Nephropathy in People With Diabetes. Prevalence and

      Recruiting
      • Chronic Kidney Diseases
      • +6 more
      • Kidney Biopsy
      • Skejby, Aarhus, Denmark
      • +9 more
      Mar 15, 2022

      Diabetes, Type 2 Diabetes, Type 1 Diabetes Trial in Shatin

      Recruiting
      • Diabetes Mellitus
      • +10 more
        • Shatin, Hong Kong
          Prince of Wales Hospital
        Mar 7, 2022

        Diabetic Kidney Disease, Diabetic Nephropathies, Diabetes, Type 2 Trial in Rochester (Autologous adipose-derived mesenchymal

        Recruiting
        • Diabetic Kidney Disease
        • +7 more
        • Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose
        • Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Mar 11, 2022

        Diabetic Kidney Disease Trial in Worldwide (Fulacimstat (BAY1142524), Placebo)

        Completed
        • Diabetic Kidney Disease
        • Fulacimstat (BAY1142524)
        • Placebo
        • Dimitrovgrad, Bulgaria
        • +26 more
        Feb 16, 2022

        Diabetic Kidney Disease Trial in San Diego (Tc-99m-Tilmanocept)

        Recruiting
        • Diabetic Kidney Disease
        • Tc-99m-Tilmanocept
        • San Diego, California
          UC San Diego Medical Center
        Feb 16, 2022

        Diabetic Kidney Disease, Hyperuricemia, Diabetes Trial in Aurora (Pegloticase 8 MG/ML [Krystexxa])

        Recruiting
        • Diabetic Kidney Disease
        • +7 more
        • Pegloticase 8 MG/ML [Krystexxa]
        • Aurora, Colorado
          Children's Hospital Colorado
        Feb 1, 2022

        Automatic Segmentation Ultrasound-based Radiomics Technology in

        Completed
        • Diabetic Kidney Disease
        • ultrasonic imaging
        • Fuyang, Anhui, China
        • +2 more
        Feb 15, 2022

        Type1diabetes, Type1 Diabetes, Diabetic Kidney Disease Trial in Aurora (Starbucks® Cold brew - 325ml bottle)

        Completed
        • Type1diabetes
        • +6 more
        • Starbucks® Cold brew - 325ml bottle
        • Aurora, Colorado
          Children's Hospital Colorado
        Jan 26, 2022

        Type 2 Diabetes, Obesity, Bariatric Surgery Candidate Trial in Aurora (Aminohippurate Sodium Inj 20%, Iohexol Inj 300 mg/mL,

        Recruiting
        • Type 2 Diabetes Mellitus
        • +11 more
        • Aminohippurate Sodium Inj 20%
        • +3 more
        • Aurora, Colorado
          Children's Hospital Colorado
        Jan 28, 2022

        Type 1 Diabetes, Nephropathy, Albuminuria Trial in Gentofte (Pro-/prebiotic Mix, Placebo)

        Recruiting
        • Type 1 Diabetes
        • +3 more
        • Pro-/prebiotic Mix
        • Placebo
        • Gentofte, Denmark
          Steno Diabetes Center Copenhagen
        Feb 9, 2022

        CKD, Diabetic Kidney Disease, Type 2 Diabetes in Obese Trial in Danville, Wilkes-Barre (Semaglutide 2 mg/1.5 ml (1.34 mg/ml),

        Recruiting
        • CKD
        • +4 more
        • Semaglutide 2 mg/1.5 ml (1.34 mg/ml), prefilled pen-injector for subcutaneous injection solution
        • Placebo 1.5 ml, prefilled pen-injector for subcutaneous injection solution
        • Danville, Pennsylvania
        • +1 more
        Feb 3, 2022